Atlas Trials

Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV

Clinical trial NCT00246402 · COMPLETED

Trial details

NCT number
NCT00246402
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Insulin ResistanceCardiovascular DiseasesHeart DiseasesHIV InfectionsHypertriglyceridemiaHyperlipidemia
Start date
2002-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.